Hypoglycaemia is a frequent adverse effect of treatment of diabetes mellitus with insulin and
sulphonylureas. Fear of hypoglycaemia alters self-management of diabetes mellitus and …

As intensive treatment to lower levels of HbA1c characteristically results in an increased risk
of hypoglycaemia, patients with diabetes mellitus face a life-long optimization problem to …

OBJECTIVE To define the threshold for excess glucose variability (GV), one of the main
features of dysglycemia in diabetes. RESEARCH DESIGN AND METHODS A total of 376 …

Objective: To review the evidence about the impact of hypoglycemia on patients with
diabetes that has become available since the past reviews of this subject by the American …

Accurate prediction of blood glucose variations in type 2 diabetes (T2D) will facilitate better
glycemic control and decrease the occurrence of hypoglycemic episodes as well as the …

The control of diabetes is an interdisciplinary endeavor, which includes a significant
biomedical engineering component, with traditions of success beginning in the early 1960s …

Glycated hemoglobin A 1c (A1C) levels have traditionally been the gold standard for
assessing glycemic control and treatment efficacy in patients with type 2 diabetes. However …

Hypoglycemia caused by treatment with a sulfonylurea, a glinide, or insulin coupled with
compromised defenses against the resulting falling plasma glucose concentrations is a …

Glucose control, glucose variability (GV), and risk for hypoglycemia are intimately related,
and it is now evident that GV is important in both the physiology and pathophysiology of …

Hypoglycemia, caused by treatment with insulin, a sulfonylurea, or a glinide coupled with
compromised defenses against falling plasma glucose concentrations, is the limiting factor …